T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia

A Mardiros, SJ Forman, LE Budde - Current opinion in hematology, 2015 - journals.lww.com
A Mardiros, SJ Forman, LE Budde
Current opinion in hematology, 2015journals.lww.com
T cells expressing CD123 chimeric antigen receptors for trea... : Current Opinion in Hematology
T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia
: Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
November 2015 - Volume 22 - Issue 6 Previous Article Next Article HEMATOPOIETIC STEM …
Summary
CD123 is an attractive surface target for novel antileukemic therapies. CD123 CAR T-cell-based immunotherapy is a promising treatment for patients with relapsed or refractory acute myeloid leukemia.
Lippincott Williams & Wilkins